HCV Grants:
HCV, HIV & HIV/HCV Harm Reduction Research
Projects

USA Population Positive for HCV
Society
in Jeopardy
The
largest public health patient
notification in the history of
the USA occurred this year, FY 2008.
Public health sent in excess of 70,000, letters warning of
possible HCV exposure from unsafe medical practices involving
several clinics.[11]
Following a joint investigation with the Nevada State Bureau of
Licensure and Certification (BLC) and with consultation from the
CDC, identified the re-use of syringes (not needles) and the use of
single dose vials of anesthesia medication on multiple patients, as
the potential sources of contamination.
The Southern Nevada Health District
reported that 200 people are testing positive daily in public health
departments.
[12] Ironically, the
head of the CDC, Julia Louise Gerberding says; "The outbreak of HCV
may represent the tip of an iceberg” of safety problems at clinics
around the country".
[13]
After similar outbreaks
in New York, the FDA has rejected that state's request to ban
multidose vials[14],
saying the vials are critical in hospital use.
[15]
The CDC says, "Use all vials labeled as "single-use" for one patient
and entered one time only". "Assign medications packaged as
multidose to a single patient whenever possible."
[16]
Multidose
vials fail in comparison to the
impertinence for standard procedures. The World Health Organization
states, "The only means of protection from the Hepatitis C virus are
the implementation universal precautions and safe injection
practices." Nation-wide, from 2004-2008, tens of thousand medical
exposures to HCV have occurred with an undetermined number of
positive infections because of policy differences. Medical exposures
surpass any other risk factor for HCV infections.[17]

HCV Harm Reduction Grants
|
Grants |
Project Number |
Researcher |
Cost |
Project Title |
|
NCRR |
5M01RR000827-33 |
HAHN, JUDITH |
$424,754 |
EFFECTS OF METHAMPHETAMINE & HCV |
|
NIAAA |
1R21AA017252-01A1 |
MUIR, ANDREW |
$224,250 |
Integrated Treatment of Persons with Co-Occurring HCV and
Alcohol Use/Abuse |
|
NIDA |
5R01DA023570-02 |
GARCIA-TSAO, GUADALUPE |
$244,622 |
Stabilize Addiction/Affect, Begin Inmates' Interferon for
HCV of Liver (STAABIHL) |
|
$420,608 |
5K23DA018623-05 |
FLOTTE, TERENCE |
$175,986 |
Pre-Chemotherapeutic Care of HCV Infected Drug Users |
|
NIAAA |
5R01AA016231-03 |
RANEY, KEVIN |
$389,191 |
Lifetime Drinking Patterns & HCV Treatment Outcomes |
|
NIDA |
5R01DA016078-07 |
STERLING, RICHARD |
$712,636 |
The Progression of Hepatitis C Among IDUs |
|
$2,843,420 |
5R01DA016159-05 |
EINAV, SHIRIT |
$650,470 |
Acute HCV Infection in Injection Drug Users |
|
|
5R01DA016017-06 |
OTT, MELANIE |
$466,965 |
Acute Hepatitis C Infection in Young Injectors |
|
|
1K23DA022454-01A1 |
LIU, HONGJIE |
$178,897 |
Directly Observed Hepatitis C Treatment in Methadone Clinics |
|
|
1R01DA021550-01A2 |
EINAV, SHIRIT |
$834,452 |
HCV Transmission among Young IDUs in NYC |
|
|
Total Spending |
$4,302,223 |
|
|
NIH Spends Most of HCV Harm Reduction
Funding for HIV/ Coinfection, Drug & Alcohol Abuse |
|
Grants |
Project Number |
Researcher |
Cost |
Project Title |
|
FIC |
5R01TW006972-04 |
RANEY, KEVIN |
$51,202 |
Risk Factors for HIV-1 infection Among Young
Thai Men |
|
NIAAA |
2R37AA014372-06A1 |
SHOHDY, NADIM |
$368,063 |
HCV, Alcohol and Host Defense |
|
$2,034,407 |
3R13DA026294-01S1 |
HELLER, THEO |
$15,000 |
Sino-US Symposium in Drug Abuse, HIV and HCV
Comorbidity |
|
|
5R01AA015201-03 |
NORTH, CAROL |
$682,443 |
Psychoeducation for HCV and Alcohol Behaviors |
|
|
5R01AA008169-19 |
TARAKHOVSKY, ALEXANDER |
$323,323 |
HCV in Alcoholics |
|
|
5R01AA012863-09 |
TAYLOR, LYNN |
$501,982 |
Mechanisms of Liver Injury by Hepatitis C and
Alcohol |
|
|
1F31AA017853-01 |
WHITE, DONNA |
$40,972 |
Effect of alcohol and opioids on DC function in
HCV and HIV infection |
|
|
1R01AA018001-01 |
MCCANCE-KATZ, ELINORE |
$437,882 |
Interaction of Alcohol and HAART in HIV/AIDS and
HIV/AIDS and HCV Coinfection |
|
|
3R01AA015201-02S1 |
NORTH, CAROL |
$32,805 |
Psychoeducation for HCV and Alcohol Behaviors |
|
NIDA |
5K01DA017179-05 |
RAY, RATNA |
$169,492 |
HCV Treatment Cost-Effectiveness in 3 IDU
Populations |
|
$4,478,757
|
5R01DA020781-03 |
MASSON, CARMEN |
$331,144 |
Hepatitis Care Coordination in Methadone
Treatment |
|
|
1R21DA023893-01A1 |
LO RE, VINCENT |
$215,840 |
Mediation Effect of Network Function on
Transition to Injection Drug Use |
|
|
5R01DA010164-12 |
BOURGOIS, PHILIPPE |
$360,811 |
The Logics for HIV Risk Among Homeless Heroin
Injectors |
|
|
5R01DA022177-02 |
HOWARD, ANDREA |
$402,864 |
Opioids, HIV/HCV and Host Cell Innate Immunity |
|
|
5R01DA020841-03 |
PANDEY, JANARDAN |
$354,372 |
Hepatitis Care Coordination in Methadone
Treatment |
|
|
5R01DA022030-03 |
BROWN, LAWRENCE |
$179,626 |
Electronic Information System to Enhance
Practice at an Opioid Treatment Program |
|
|
5K01DA023365-02 |
HARTGE, PATRICIA |
$165,521 |
Dynamic Modeling of the HCV Epidemic in IDU |
|
|
5R01DA019383-04 |
GALE, MICHAEL |
$599,233 |
Staying Safe: Long-Term Injection Drug Users Who
Have Avoided HIV & Hepatitis C |
|
|
1K23DA020383-01A1 |
SPRATT, HEIDI |
$179,212 |
Buprenorphine as a Bridge to HCV Treatment for
HIV/HCV Coinfected Opioid Users |
|
|
5R01DA019829-04 |
SCOTT, JOHN |
$706,524 |
Epidemiology of HIV and Hepatitis C Among
Injecting Drug Users in Tijuana |
|
|
5R21DA023399-02 |
RAISON, CHARLES |
$150,780 |
Reducing HIV Risk Among Methamphetamine IDUs
Through Peer Education |
|
|
3R01DA019829-03S1 |
SCOTT, JOHN |
$54,773 |
Epidemiology of HIV and Hepatitis C Among
Injecting Drug Users in Tijuana |
|
|
2R01DA016065-06A1 |
SHERMAN, KENNETH |
$402,468 |
HCV Disease Management in HIV- HCV Coinfected
IDUs |
|
|
1R13DA026294-01 |
HELLER, THEO |
$25,000 |
Sino-US Symposium in Drug Abuse, HIV and HCV
Comorbidity |
|
|
3R01DA022177-01A1S2 |
HOWARD, ANDREA |
$7,020 |
Opioids, HIV/HCV and Host Cell Innate Immunity |
|
|
5K23DA022143-03 |
BRUCE, ROBERT |
$174,077 |
Substance Abuse, HIV and HCV Treatments to
Improve Health Outcomes in Drug Users |
|
|
Total Spending |
$6,932,429 |
|
|
|